Thryv Therapeutics, Inc.
Clinical trials sponsored by Thryv Therapeutics, Inc., explained in plain language.
-
New heart drug aims to tame deadly rhythm disorder
Disease control Recruiting nowThis study is testing a new drug called THRV-1268 to see if it can safely shorten a dangerous heart rhythm interval in people with Long QT Syndrome Type 2. About 64 participants will take the drug at different doses for several weeks while doctors closely monitor their heart's el…
Phase: PHASE2, PHASE3 • Sponsor: Thryv Therapeutics, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Heart condition patients track life impact in groundbreaking app study
Knowledge-focused Recruiting nowThis study aims to understand how Long QT Syndrome types 2 and 3 affect people's daily lives, emotions, and overall well-being. Researchers will enroll 200 adults with these genetic heart conditions to complete surveys and use an iPhone and Apple Watch to track their health metri…
Sponsor: Thryv Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 22:26 UTC